Apoptosis Research Unit

	Profile

The Apoptosis Research Unit analyses cell death in health and disease

The Unit under the Director, Associate Professor Glenda Gobe has been concerned with experimental molecular strategies aimed at improving patient outcomes, particularly related to acute and chronic renal diseases. Acute renal failure is a common, life-threatening condition that affects approximately 2500 Australians each year and culminates in their death in over 50% of cases.

One of the main problems globally is the increase – 6-8% per year - of chronic renal disease. End stage renal disease results in around 80,000 deaths globally per annum and costs approximately $US22 billion. Our work delves into the molecular pathways that control development of these diseases. We are applying our results to realistic develop drug and gene therapies. We are also analysing how some current drugs and alternative therapies work.

We have worked actively with the Blue Sky Foundation and Southern Cross University’s School of Natural and Complimentary Medicines to test how novel alternative and complimentary medicines work in combating chronic renal disease.

Our consultancy, ApoTec Research Services, offers cell death identification and quantification for other research groups. Check the "programs" link to the left of this screen to view our projects, staff and students, and post-graduate studies that are available.

For queries about any project, email Associate Professor Glenda Gobe, g.gobe@uq.edu.au

	Images
		Apoptosis Research Unit (L-R) Jun Li, Mitra Mahmoudi, Leila Cuttle, Betty Pat, Christine Percy, Glenda Gobe (seated)